I Bella Perfect, which operates three aesthetic medical clinics in Malaysia, raised the proposed deal size for its upcoming IPO on Tuesday.
The Kuala Lumpur, Malaysia-based company now plans to raise $19 million by offering 3.8 million shares at a price range of $4 to $6. The company had previously filed to offer 1.9 million shares at the same range. At the midpoint, I Bella Perfect will raise 100% more in proceeds than previously anticipated.
I Bella Perfect operates three aesthetic medical clinics in the central and southern regions of Malaysia, providing non-invasive and minimally invasive procedures including facial and skin treatments, body contouring, and laser therapies. The company offers services such as skin tightening, botulinum toxin injections, and filler injections, while also selling a range of five branded skincare products including facial cleansers and creams formulated by original equipment manufacturers. In the year ended March 31, 2025, it served 5,985 customers across its Kuala Lumpur, Selangor, and Johor locations.
I Bella Perfect was founded in 2012 and booked $5 million in revenue for the 12 months ended September 30, 2025. It plans to list on the Nasdaq under the symbol IBL. Cathay Securities is the sole bookrunner on the deal.
